Case study

Addressing an Evidentiary Gap With Real-World Prospective Studies

Learn how Xcenda helped one client address an evidence gap for a revolutionary new orphan drug.

Related resources

Article

How MFN is reshaping global market access

Webinar

Reducing missed evidence with AI‑enabled literature mining

Article

EU JCA and US MFN collision: The next global pricing and market access risk frontier